What Pharmacists Need to Know About HIV Treatment and Prevention
1.1 million Americans live with HIV-here’s how you can help.
Pediatric Problems, and How Pharmacists Can Solve Them
The smallest patients can sometimes present the biggest issues.
Pharmacogenomics and the Future of Pharmacy
Why it’s vital for pharmacists to learn about this emerging field.
Study Finds Majority of Patients Using Insulin Glargine Past Recommended Expiration
Insulin glargine should not be used past 28 days after the vial is first used, but 80% of patients do.
Empagliflozin Reduced Liver Fat in Type 2 Patients with Nonalcoholic Fatty Liver Disease
Diabetes drug empagliflozin reduces fat levels in type 2 patients, which may reduce risk of severe liver disease.
Missing Teeth Could Be Linked to Diabetes Risk
Missing teeth could be a signal that diabetes may be developing.
The Surgeon General Wants More Naloxone, Now What?
What do pharmacies have to do with the recent Surgeon General Advisory? A lot, actually.
New Migraine Meds Pharmacists Need to Know About
New drugs for acute migraines are almost ready for prime time. Here's what you need to know.
Apixaban, Warfarin Equally Safe, Study Finds
A study found that apixaban is a safe alternative to VKAs for ablation of atrial fibrillation.
New Bleeding Reversal Agent Shows Promise
Andaxanet alfa has shown effectiveness for patients needing hemostasis.
Pediatric Patients Present Unique Challenges to Pharmacists
Board-certified pharmacists are better prepared to deal with pediatric patients than others. Here’s why.
Diabetes Management and the Promise of Telemedicine
Could telemedicine be the answer to diabetes management problems?
A Pharmacist Makes the Case Against Legalizing Marijuana
The legalization of marijuana has consequences.
MS Drug Removal Leaves Patients with Fewer Options
Zinbryta was taken off the market, leaving many patients with poor options.
Urinary Incontinence: What Pharmacists Should Know
Up to 30% of the population is affected by the problem, this peer-reviewed article will give you the information you need.
Are More Blister Packs a Good Thing?
In an effort to combat opioids, the FDA is pushing blister packs-something pharmacy groups have been advocating for.
Pharmacists on the Front Line in Treating Cardiac Disease
When it comes to cardiac disease, pharmacists in all practice settings can make a difference.
Walgreens Teams Help Oncology Patients
The chain patented new tech to help better manage oncolytic usage.
Months Later, Drug Shortages Still a Problem
Will healthcare manufacturing in Puerto Rico be back on its feet by next hurricane season?
The New Type 2 Diabetes Technologies Pharmacists Need to Know About
Pharmacists need to stay informed about new technologies in order to help diabetic patients take advantage.
As Diabetes Numbers Rise, Costs Mount
The pharmacist's role in diabetes care will only continue to grow.
FDA Adds New Compounding Pharmacy Regulations
New plans are designed around feedback and a desire to increase safety checks.
Why Walmart Thinks a Gel Could Stop Opioid Abuse
How a gel could prevent opioid abuse and get pharmacists more involved.
FDA: Opioid Cold Meds Not Safe for Kids
The agency’s ruling also added an additional Boxed Warning.
Pharmacy Tech Brings U.S. Guidelines Overseas
Air Force SSgt Mary Johnson was named the 2017 PTCB CPhT of the Year for her work.
Wellness Visits/Pharmacists: Perfect Together
Study finds that patients like wellness visits conducted by pharmacists.
Are Community Pharmacists an Untapped Resource in Fighting Antifungal Resistance?
Anti-fungal resistance hasn't gotten much attention - but it's a big problem.
Specialty Pharmacy Will Gain a Bigger Chunk of U.S. Pharmaceuticals
The specialty explosion is only going to get bigger.
A Boxed Warning Goes Away
A rare removal of a box warning after large-scale clinical trials.
How Pharmacists Can Protect Kids from Dangerous Medications
Kids getting into medications is a big problem, but pharmacists can help.